Have I discussed GLP-1 treatment with my primary care physician
Differentiating between patients with WR and IWL, no significant differences in weight loss response were found
Thus, a comprehensive understanding of PD pathogenesis requires integrating this multicellular network, in which neuronal vulnerability is shaped by dysregulated interactions among neurons, glia, vascular cells, and peripheral immune components
Healthcare professionals should maintain a low threshold for investigating potential biliary pathology in patients on GLP-1 agonists who present with compatible symptoms
The key factor in efficacy is compliance, because the oral version requires strict adherence to the empty stomach rule
If you moved from 0.5 mg to 1 mg within the last 4 weeks, your body is still adapting to the higher dose